The results of this 12‐months analysis documented the overall low incidence of COVID‐19 infection in CLL patients (3.3%), similar to that of the normal population in Italy. Patients ‘age and severity of the disease did not vary significantly in the two high‐incidence pha- ses, confirming that CLL patients with COVID‐19 are at a relatively high risk of intensive oxygen support despite improvement in the diagnostic tracing and definition of anti‐COVID‐19 treatment protocols
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL report
Quaglia, Francesca Maria;
2021-01-01
Abstract
The results of this 12‐months analysis documented the overall low incidence of COVID‐19 infection in CLL patients (3.3%), similar to that of the normal population in Italy. Patients ‘age and severity of the disease did not vary significantly in the two high‐incidence pha- ses, confirming that CLL patients with COVID‐19 are at a relatively high risk of intensive oxygen support despite improvement in the diagnostic tracing and definition of anti‐COVID‐19 treatment protocols
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
